跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 108 条关于
“Cybb/Nox2”
全部
108
临床试验
50
药物
46
机构
1
资讯
11
2个月前
Cleveland Researchers Identify 15-PGDH as Promising Drug Target for Parkinson's Disease
12个月前
Ensoma Secures $53 Million to Advance First-in-Class Gene Therapy for X-Linked Chronic Granulomatous Disease
去年
FDA Clears IND for Ensoma's First-in-Class In Vivo Gene Therapy for X-Linked Chronic Granulomatous Disease
4个月前
Ensoma Reports First Clinical Safety Data for Groundbreaking In Vivo Hematopoietic Stem Cell Gene Therapy
去年
Adenine Base Editing Shows Promise in X-Linked Chronic Granulomatous Disease Trial
3个月前
Urinary MMP-1 Identified as Potential Biomarker for Calcium Oxalate Kidney Stone Disease
去年
TME Pharma Implements Strategic Restructuring to Advance NOX-A12 and NOX-E36 Development
2年前
NOX Inhibitors Show Promise in Fibrotic Diseases and Cancer Treatment
去年
Australian Researchers Identify NOD2 Gene Variants as Key to Enhanced Cancer Immunotherapy Response
去年
TME Pharma's NOX-A12 Shows Significant Survival Benefit in Glioblastoma Trial
第 1 页,共 2 页
上一页
下一页